pioglitazone has been researched along with Cataract, Membranous in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of pioglitazone also protected the secondary structural alterations induced by glycation and inhibited the formation of protein aggregates." | 5.72 | Ameliorative effect of pioglitazone on glucose induced glycation of α-crystallin: Management of complications associated with diabetic retinopathy. ( Ren, Z; Song, J, 2022) |
| "Treatment of pioglitazone also protected the secondary structural alterations induced by glycation and inhibited the formation of protein aggregates." | 1.72 | Ameliorative effect of pioglitazone on glucose induced glycation of α-crystallin: Management of complications associated with diabetic retinopathy. ( Ren, Z; Song, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, Z | 1 |
| Song, J | 1 |
1 other study available for pioglitazone and Cataract, Membranous
| Article | Year |
|---|---|
Ameliorative effect of pioglitazone on glucose induced glycation of α-crystallin: Management of complications associated with diabetic retinopathy.
Topics: alpha-Crystallins; Cataract; Crystallins; Diabetes Mellitus; Diabetic Retinopathy; Glucose; Humans; | 2022 |